Experimental Virology

Experimental Virology

Viruses are vehicles which transmit biological information, reprogramming the function of human, animal or plant cells to produce progeny virions. Viral pathogens are very small, often with a very simple structure. Indeed, enveloped viruses are composed only of a protein shell filled with genetic material, surrounded by a lipid envelope decorated with viral proteins. Nevertheless, viral pathogens like HIV or the hepatitis C virus (HCV) threaten the health of many millions of individuals. Important human pathogens among the group of RNA viruses include hepatitis C virus (HCV) and the respiratory syncytial virus (RSV).

The institute comprises three research groups that focus on hepatitis viruses (HCV, HEV), HIV-1, respiratory syncytial virus (hRSV) and Chikungunya virus (CHIKV).

News

Job announcement: Postdoctoral Position (2 y 4 m) in the Gerold lab

The research group “Virus Interaction Proteomics” at the Institute for Experimental Virology, TWINCORE in Hannover, Germany, is recruiting a research associate (postdoc) on a 2-year 4 months position in virology to pursue a...



25. March 2019

Eliminating hepatitis C viruses effectively

TWINCORE researchers identify target on the viral envelope and develop customised agents. The treatment of hepatitis C has been based on specific effective antiviral medications for a number of years. Since future...


New Approaches for Vaccinations against Hepatitis C Virus

For a few years now infections with Hepatitis C virus can be efficiently treated and patients can be cured with modern medication. Nevertheless, researchers are looking for a vaccine against the virus, which has specialized...


23. July 2018

Protein complex for hepatitis C-virus entry in liver cells is characterised

Hepatitis C virus chronically infects 70 million individuals worldwide. Although the infection can be cured with antiviral drugs, this therapy does not protect from a second infection with the same virus. Moreover, in patients...